HOOK HOOKIPA Pharma
- 0.784
- -0.016-1.96%
HOOKIPA Pharma News
HOOKIPA Pharma | 8-K: Current report
HOOKIPA Pharma | 10-Q: Quarterly report
HOOKIPA Pharma | 8-K: HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
HOOKIPA Pharma | DEFA14A: Others
HOOKIPA Pharma | ARS: Annual Report to Security Holders
HOOKIPA Pharma | DEF 14A: Definitive information statements
HOOKIPA Pharma | 8-K: Current report
HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Necina Roman
HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Orlinger Klaus
HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Aldag Jorn
HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Winderlich Mark
HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kandera Reinhard
HOOKIPA Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
HOOKIPA Pharma | 3: Initial statement of beneficial ownership of securities-Officer Winderlich Mark
HOOKIPA Pharma | 10-K: Annual report
HOOKIPA Pharma | 8-K: HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
HOOKIPA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(4.8%),Oleg Nodelman(4.8%), etc.
HOOKIPA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%), etc.
HOOKIPA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(1.1%),Jeremy C. Green(1.1%)
HOOKIPA Pharma | 8-K: Current report
Analysis
Price Target
No Data
